Literature DB >> 646221

Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters.

R P Harvey, E S Schmid, C C Carrington, D A Stevens.   

Abstract

A murine model of pulmonary mycotic disease using Blastomyces dermatitidis is defined quantitatively. Intranasal inoculation with yeasts avoids delays in growing microconidia and can be performed with routine precautions without sophisticated biohazard facilities. The particles rapidly reach the bronchioles and alveoli, producing a progressive focal pneumonia, studied histologically. In vitro growth conditions are defined to titer inocula reproducibly with visual methods. Median survival can be titrated with the challenge inocula. Although initial postchallenge lung cultures are not always positive, replication eventually proceeds, at a rate defined for various challenge sizes, to a ceiling of 10(7) to 10(8) colony-forming units per g of tissue incompatible with life. Lung weight correlates closely with colony-forming units per g above a threshold. Lethality correlates with initial body weight and with age. During the course of infection, weight is an accurate predictor of mortality. Extrapulmonary dissemination occurs as a premortem event in protracted infections. A wide variation in fungal strain virulence is documented. Quantification of these features of the model makes it useful for study of host response or therapeutic intervention, because efficacy can be related to stage of disease and parasitic burden.

Entities:  

Mesh:

Year:  1978        PMID: 646221     DOI: 10.1164/arrd.1978.117.4.695

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  45 in total

1.  Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates.

Authors:  C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

Review 2.  Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.

Authors:  K N Sorensen; K V Clemons; D A Stevens
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

3.  In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.

Authors:  A M Sugar; X P Liu
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing.

Authors:  C J Morrison; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

5.  Evolution of inflammatory response and cellular immune responses in a murine model of disseminated blastomycosis.

Authors:  G S Deepe; C L Taylor; W E Bullock
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

6.  Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence.

Authors:  L H Hogan; B S Klein
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Altered expression of surface protein WI-1 in genetically related strains of Blastomyces dermatitidis that differ in virulence regulates recognition of yeasts by human macrophages.

Authors:  B S Klein; S Chaturvedi; L H Hogan; J M Jones; S L Newman
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Virulence of fungi: correlation of virulence of Blastomyces dermatitidis in vivo with escape from macrophage inhibition of replication in vitro.

Authors:  E Brummer; P A Morozumi; D E Philpott; D A Stevens
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

9.  Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent.

Authors:  A M Sugar; M Picard; L Noble
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

10.  Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis.

Authors:  R M Tucker; L H Hanson; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.